乳腺原发性血管肉瘤:单独的手术与化疗和/或放射治疗- 一个系统性审查和元分析
Konstantinos Skarentzos1, Anastasia Kourtesa2, Abraham Pouliakis1
1Second Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 12462 Athens, Greece.
Cancers
|February 27, 2026
概括
组织学等级是乳腺原发性血管肉瘤 (PAB) 的关键预后因素. 辅助化疗显著改善了生存率,而放射治疗没有,为治疗策略提供了关键证据.
科学领域:
- 在瘤学瘤学.
- 手术病理学手术病理学
- 临床瘤学临床瘤学
背景情况:
- 乳腺原发性血管肉瘤 (PAB) 是一种罕见的癌症,治疗指南尚不确定.
- 由于缺乏标准化方案,需要对预后因素和治疗疗效进行研究.
研究的目的:
- 确定瘤等级对PAB的整体存活时间 (OS) 的影响.
- 评估辅助化疗和放射治疗与PAB生存结果的关联.
主要方法:
- 在PubMed,Scopus和Cochrane图书馆进行系统的文献搜索.
- 独立的数据提取和偏差风险评估 (纽卡斯尔-太华尺度).
- 卡普兰-梅尔曲线的数字化和随机效应的元分析.
主要成果:
- 包括11项研究 (436名患者).
- 更高的瘤等级 (等级2vs1:HR 1.2;等级3vs1:HR 3.7) 显著预测死亡率.
- 辅助化疗显示出显著的生存益处 (HR = 0.11),而放射治疗没有 (p = 0.96).
结论:
- 组织学等级是PAB的关键预后因素.
- 辅助化疗与PAB患者的生存率改善密切相关.
- 研究结果支持化学疗法用于PAB的多式疗法,并有助于风险分层.
相关概念视频
Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K


